Comparison
While DSIP was originally described for inducing spindle and delta sleep activity when infused into the brain of rabbits; later studies report stress-modulating and endocrine effects, though its physiological role is still debated47, Liraglutide is approved for type 2 diabetes and weight management, improving glycemic control and inducing weight loss through GLP-1–mediated insulinotropic, glucagonostatic, and appetite-suppressing actions6880.
While DSIP works as an endogenous nonapeptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, with proposed neuromodulatory actions; it interacts with components of the MAPK cascade and may be related to glucocorticoid-induced leucine zipper (GILZ), but its precise biosynthetic origin remains unknown4757, Liraglutide is a human GLP-1 analog with a single amino-acid substitution (Lys34→Arg) and a C16 palmitoyl fatty acid attached to Lys26 via a glutamate linker, producing a long-acting GLP-1 receptor agonist6880.
DSIP is 9 amino acids long, whereas Liraglutide is longer as it has a length of 31 amino acids. DSIP is made up of a sequence of Tryptophan, Alanine, Glycine, Glycine, Aspartic acid, Alanine, Serine, Glycine, Glutamic acid. Liraglutide is made up of a sequence of sequence data not available in the current dataset.
DSIP
Not assigned in the current dataset.
Liraglutide
GCG